National Asset Management, Inc. Cara Therapeutics, Inc. Transaction History
National Asset Management, Inc.
- $3.51 Billion
- Q3 2024
A detailed history of National Asset Management, Inc. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, National Asset Management, Inc. holds 58,458 shares of CARA stock, worth $303,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,458
Previous 61,608
5.11%
Holding current value
$303,981
Previous $16,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CARA
# of Institutions
12Shares Held
886KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY745KShares$3.87 Million0.0% of portfolio
-
American Portfolios Advisors Holbrook, NY40.4KShares$210,2100.02% of portfolio
-
Rathbones Group PLC Liverpool, X020.2KShares$104,8520.0% of portfolio
-
Rothschild Investment Corp10.6KShares$55,1200.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ8.83KShares$45,9310.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $279M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...